Nabriva Therapeutics Ag Stock Technical Analysis
| NBRVDelisted Stock | USD 1.62 0.01 0.61% |
As of the 4th of December, Nabriva Therapeutics secures the Mean Deviation of 3.33, risk adjusted performance of 0.0282, and Downside Deviation of 5.56. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nabriva Therapeutics, as well as the relationship between them. Please verify Nabriva Therapeutics mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if Nabriva Therapeutics AG is priced some-what accurately, providing market reflects its recent price of 1.62 per share. Please also check out Nabriva Therapeutics total risk alpha, which is currently at (0.54) to check the company can sustain itself at a future point.
Nabriva Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nabriva, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NabrivaNabriva |
Nabriva Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Nabriva Therapeutics Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Nabriva Therapeutics Trend Analysis
Use this graph to draw trend lines for Nabriva Therapeutics AG. You can use it to identify possible trend reversals for Nabriva Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Nabriva Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Nabriva Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Nabriva Therapeutics AG applied against its price change over selected period. The best fit line has a slop of 0.0019 , which may suggest that Nabriva Therapeutics AG market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.13, which is the sum of squared deviations for the predicted Nabriva Therapeutics price change compared to its average price change.About Nabriva Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nabriva Therapeutics AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nabriva Therapeutics AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Nabriva Therapeutics price pattern first instead of the macroeconomic environment surrounding Nabriva Therapeutics. By analyzing Nabriva Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nabriva Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nabriva Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Nabriva Therapeutics December 4, 2024 Technical Indicators
Most technical analysis of Nabriva help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nabriva from various momentum indicators to cycle indicators. When you analyze Nabriva charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0282 | |||
| Market Risk Adjusted Performance | (0.17) | |||
| Mean Deviation | 3.33 | |||
| Semi Deviation | 4.98 | |||
| Downside Deviation | 5.56 | |||
| Coefficient Of Variation | 3857.27 | |||
| Standard Deviation | 4.83 | |||
| Variance | 23.37 | |||
| Information Ratio | 0.0025 | |||
| Jensen Alpha | 0.1826 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.0022 | |||
| Treynor Ratio | (0.18) | |||
| Maximum Drawdown | 32.85 | |||
| Value At Risk | (6.02) | |||
| Potential Upside | 5.52 | |||
| Downside Variance | 30.88 | |||
| Semi Variance | 24.78 | |||
| Expected Short fall | (3.35) | |||
| Skewness | (0.06) | |||
| Kurtosis | 3.8 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Nabriva Stock
If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |